Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
about
Comparative methodological analysis of erbB-2/HER-2 gene dosage, chromosomal copy number and protein overexpression in breast carcinoma tissues for diagnostic useCD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration.The breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis.Limitations in Adjuvant Breast Cancer Therapy: The Predictive Potential of Pharmacogenetics and Pharmacogenomics.A microfluidic platform for quantitative analysis of cancer angiogenesis and intravasationChemotherapy for metastatic tumors to the central nervous system.Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.Stepping out of the flow: capillary extravasation in cancer metastasis.A novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44.Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.Expression of c-erbB-2, p53 and c-myc proteins in male breast carcinoma: Comparison with traditional prognostic factors and survival.Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells.The interrelating dynamics of hypoxic tumor microenvironments and cancer cell phenotypes in cancer metastasis.The HER2 status of disseminated tumor cells in the bone marrow of early breast cancer patients is independent from primary tumor and predicts higher risk of relapse.c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma.Plasma gelatinase levels in patients with primary breast cancer in relation to axillary lymph node status, Her2/neu expression and other clinicopathological variables.
P2860
Q28140514-3108A7C0-DAB5-46EE-8CEB-288E05634584Q33324402-850F4E76-EBEB-4054-BDBC-BE28148AB120Q33943941-AA6046BF-EA5B-417D-88E4-E0077C7CD7B3Q34095952-A0171E13-CA1C-4381-8B4F-AA099E21FEAEQ34305984-B33EF7B7-6D21-46F8-AEDF-320AA867949CQ34397781-D3648610-489F-487B-9F50-1FB7540E1E2DQ34535370-2DA683D5-8068-4630-A57C-73984B411DA7Q36956344-E89536FF-7635-4386-885C-579869AD5BC3Q37690517-FDF6F369-C2C7-4EDB-AAC1-C39A498BB581Q38433814-90088A94-E81B-45D3-93A4-7144CFF2551EQ38460494-50654C8A-18ED-42F3-8CFF-57E7FE1B1B7BQ39767027-04AF5FEA-7094-4AAC-8102-E91BE7751D1FQ41953800-A2D00FD8-543E-427E-B047-F04665E070B1Q44503403-DBC5BC8B-7809-45CE-A3B6-B16B6B70D25FQ52122642-A46D1A8D-3B96-4086-A514-328F3EC35AC6Q53351916-6E7023D9-0703-48EB-AF99-4F2BEDBF0C94
P2860
Selection of potentially metastatic subpopulations expressing c-erbB-2 from breast cancer tissue by use of an extravasation model.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
1998年论文
@zh
1998年论文
@zh-cn
name
Selection of potentially metas ...... use of an extravasation model.
@ast
Selection of potentially metas ...... use of an extravasation model.
@en
type
label
Selection of potentially metas ...... use of an extravasation model.
@ast
Selection of potentially metas ...... use of an extravasation model.
@en
prefLabel
Selection of potentially metas ...... use of an extravasation model.
@ast
Selection of potentially metas ...... use of an extravasation model.
@en
P2093
P2860
P1476
Selection of potentially metas ...... use of an extravasation model.
@en
P2093
P2860
P304
P356
10.1016/S0002-9440(10)65694-5
P407
P577
1998-12-01T00:00:00Z